Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

540 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transcatheter edge-to-edge mitral valve repair in heart failure.
Orban M, Orban M, Braun D, Nabauer M, Massberg S, Hausleiter J. Orban M, et al. Among authors: massberg s. Minerva Cardioangiol. 2017 Jun;65(3):314-320. doi: 10.23736/S0026-4725.16.04287-0. Epub 2016 Dec 13. Minerva Cardioangiol. 2017. PMID: 27958694 Review.
Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting versus Zotarolimus-eluting Stents (ISAR-TEST 5) trial.
Massberg S, Byrne RA, Kastrati A, Schulz S, Pache J, Hausleiter J, Ibrahim T, Fusaro M, Ott I, Schömig A, Laugwitz KL, Mehilli J; Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting Versus Zotarolimus- Eluting Stents (ISAR-TEST 5) Investigators. Massberg S, et al. Circulation. 2011 Aug 2;124(5):624-32. doi: 10.1161/CIRCULATIONAHA.111.026732. Epub 2011 Jul 18. Circulation. 2011. PMID: 21768546 Clinical Trial.
Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial.
Mehilli J, Pache J, Abdel-Wahab M, Schulz S, Byrne RA, Tiroch K, Hausleiter J, Seyfarth M, Ott I, Ibrahim T, Fusaro M, Laugwitz KL, Massberg S, Neumann FJ, Richardt G, Schömig A, Kastrati A; Is Drug-Eluting-Stenting Associated with Improved Results in Coronary Artery Bypass Grafts? (ISAR-CABG) Investigators. Mehilli J, et al. Among authors: massberg s. Lancet. 2011 Sep 17;378(9796):1071-8. doi: 10.1016/S0140-6736(11)61255-5. Epub 2011 Aug 26. Lancet. 2011. PMID: 21872918 Clinical Trial.
Time does not heal all wounds: very late stent thrombosis eight years after implantation of a sirolimus-eluting stent due to positive remodelling, saccular evaginations and marked vascular inflammation.
Orban M, Joner M, Riegger J, Steigerwald K, Tada T, Ibrahim T, Laugwitz KL, Byrne RA, Kastrati A, Massberg S. Orban M, et al. Among authors: massberg s. EuroIntervention. 2013 Jul;9(3):412-3. doi: 10.4244/EIJV9I3A66. EuroIntervention. 2013. PMID: 23034199 Free article. No abstract available.
A novel role of sphingosine 1-phosphate receptor S1pr1 in mouse thrombopoiesis.
Zhang L, Orban M, Lorenz M, Barocke V, Braun D, Urtz N, Schulz C, von Brühl ML, Tirniceriu A, Gaertner F, Proia RL, Graf T, Bolz SS, Montanez E, Prinz M, Müller A, von Baumgarten L, Billich A, Sixt M, Fässler R, von Andrian UH, Junt T, Massberg S. Zhang L, et al. Among authors: massberg s. J Exp Med. 2012 Nov 19;209(12):2165-81. doi: 10.1084/jem.20121090. Epub 2012 Nov 12. J Exp Med. 2012. PMID: 23148237 Free PMC article.
540 results